Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

New class of tubulin polymerization inhibitors presented in Amsterdam

Nov. 9, 2000

PC-PLD inhibitors preferentially abrogate growth and proliferation of tumor cell lines

Nov. 9, 2000

Clinical pharmacokinetics and toxicity of NX-211 characterized at major cancer meeting

Nov. 9, 2000

NCI-EORTC-AACR news: dual topoisomerase I/II inhibitors promising as solid tumor therapy

Nov. 9, 2000

Toxicity and pharmacokinetics of new camptothecin analogue CKD-602 determined in phase I trial

Nov. 9, 2000

GST P1-1-activated nitrogen mustard prodrug shows promise as cancer therapy

Nov. 8, 2000

Takara Shuzo identifies new anticancer tetrahydrofuran

Nov. 8, 2000

Preliminary clinical data on parenteral and oral BN-80915 presented at NCI-EORTC-AACR

Nov. 8, 2000

Casodex monotherapy associated with preservation of BMD and sexual interest

Nov. 8, 2000

Temple researchers identify biologically active anticancer (Z)-styryl benzylsulfones

Nov. 7, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 22, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for July 21, 2026
To viral or not to viral: In vivo CAR T debates delivery tech
BioWorld
The field of cell and gene therapy is moving toward a new phase of scalability and clinical durability, with in vivo chimeric antigen receptor (CAR) T-cell...
In vivo click ADCs could address tumor heterogeneity
BioWorld
Researchers at Washington University in St. Louis have used click chemistry to link a second antibody to a pre-existing antibody-drug conjugate (ADC) in vivo. In...
KBN-2201 reverses key features of Alzheimer’s in mice
BioWorld Science
Researchers from Ajou University School of Medicine reported the preclinical efficacy of KBN-2201 in a mouse model of late-stage Alzheimer’s disease.